Projects per year
Personal profile
Biography
A/Prof Anneke van der Walt is an academic Neurologist with subspecialty training in multiple sclerosis and neuroimmunology as well as neuro-ophthalmology. She leads the MS and Neuro-ophthalmology Research Group at the School of Translational Medicine, Monash University.
A/Prof van der Walt completed her undergraduate training in South Africa before relocating to Australia where she completed specialist training in Neurology and a PhD in Neuroscience under supervision of Professors Trevor Kilpatrick and Helmut Butzkueven at the University of Melbourne. This was followed by postdoctoral training at the Melbourne Brain Centre, UoM (2013-2017 - postdoc; 2015-2017 - senior research fellow).
A/Prof van der Walt has received substantial competitive fellowship and grant funding, totalling $17,633,282 to date from NHMRC, MRFF, inetrnational funding and several industry grants.
With a H-index of 26, her peer-reviewed published research has garnered almost 1844 citations to date.
Research interests
A/Prof van der Walt's research interests include cerebellar dysfunction in MS, and MS cognition, and women's health. She leads several large national and international studies on digital biomarkers in MS.
A/Prof van der Walt is also the Chief Operating Officer of the MSBae foundation. Her clinical roles includes appointments as the HEad, MSNI Unit and Neuro-ophthalmology Service at Alfred Health, Melbourne.
Supervision interests
A/Prof van der Walt has extensive experience supervising postdoctoral fellows, PhD students, Masters and Honours students. She currently overseas 5 post docs and 5 PhD students. Six PhD students, 1 Masters student and 5 Honours student have sucessfully completed research projects under A/Prof van der Walt's supervision.
Community service
2018-2020
- MS ATLAS meeting: Chair, Steering committee (Biogen)
2017-2018
- Atrophy in MS (AIMS) Initiative: Steering committee (Genzyme)
- MS innovations meeting
- Steering committee (Novartis, Genzyme)
2017
- Siponimod advisory Board, (Novartis)
- MS ATLAS meeting: Steering committee (Biogen)
- Cladribine advisory board, February (Merck)
2015
- Cladribine advisory board, (Merck)
- Advisory Board for Merck Serono
2010
- Advisory boards for Merck Serono
2009
- Advisory boards for Bayer Schering
Monash teaching commitment
2019
- TRM006 Translational Neuroscience Masters Degree. Seminar: Assessment of the anterior visual system and role in translation in multiple sclerosis.
2018
- Teaching of 3rd year medical students, CCS, Monash University.
University Service
2018 - ongoing
- Multiple Sclerosis Research Australia (MSRA): Research Medical Council Grant Panels
2019-2020
- MSRA Incubator Grants: Round 1 and 2
2017- 2018
- NHMRC: external assessor, Project Grants
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, University of Melbourne
2 Feb 2008 → 31 Oct 2012
Bachelor of Medicine and Surgery (MBChB), University of Pretoria
31 Jan 1993 → 30 Nov 1998
External positions
Clinical Associate Professor, University of Melbourne
30 Nov 2017 → …
Honorary Research Fellow, Bionics Institute of Australia (trading as Bionics Institute)
1 Feb 2015 → …
Consultant Neuroophthalmologist, Royal Victorian Eye & Ear Hospital (RVEEH)
1 Feb 2008 → …
Research area keywords
- Neuroscience
- Multiple Sclerosis (MS)
- Optic neuritis
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
VALUE-Ig : eVidence synthesis to inform the optimAL UsE of Immunoglobulin
Petrie, D., McQuilten, Z., Harris, A., Wood, E., Irving, A., Van Der Walt, A., Reddel, S. W., Fanning, L., Spencer, A., Hawkes, E. & Crispin, P.
1/04/22 → 31/03/26
Project: Research
-
Determining the risk of cervical precancer and cancer in women with multiple sclerosis: a national data linkage study.
Van Der Walt, A., Jokubaitis, V., Butzkueven, H., Taylor, B. V. M., Lechner-Scott, J. & Brotherton, J. M. L.
1/01/22 → 31/12/24
Project: Research
-
Big Multiple Sclerosis Data network: an international registry research network
Glaser, A., Butzkueven, H., van der Walt, A., Gray, O., Spelman, T., Zhu, C., Trojano, M., Iaffaldano, P., Battaglia, M. A., Lucisano, G., Vukusic, S., Vukusic, I., Casey, R., Horakova, D., Drahota, J., Magyari, M., Joensen, H., Pontieri, L., Elberling, F., Klyve, P., & 3 others, 2024, In: Journal of Neurology. 271, p. 3616–3624 9 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
Open Access2 Citations (Scopus) -
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom
Spelman, T., Herring, W. L., Acosta, C., Hyde, R., Jokubaitis, V. G., Pucci, E., Lugaresi, A., Laureys, G., Havrdova, E. K., Horakova, D., Izquierdo, G., Eichau, S., Ozakbas, S., Alroughani, R., Kalincik, T., Duquette, P., Girard, M., Petersen, T., Patti, F., Csepany, T., & 45 others, Dec 2024, In: Journal of Medical Economics. 27, 1, p. 109-125 17 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access -
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
Foong, Y. C., Merlo, D., Gresle, M., Buzzard, K., Zhong, M., Yeh, W. Z., Jokubaitis, V., Monif, M., Skibina, O., Ozakbas, S., Patti, F., Grammond, P., Amato, M. P., Kalincik, T., Horakova, D., Havrdova, E. K., Weinstock-Guttman, B., Scott, J. L., Boz, C., Sa, M. J., & 4 others, Aug 2024, In: Journal of Neurology, Neurosurgery and Psychiatry. 95, 8, p. 767–774 8 p., 332883.Research output: Contribution to journal › Article › Research › peer-review
3 Citations (Scopus) -
Evobrutinib in multiple sclerosis: challenges and unmet goals
van der Walt, A., Nov 2024, In: The Lancet Neurology. 23, 11, p. 1068-1070 3 p.Research output: Contribution to journal › Comment / Debate › Other › peer-review
-
Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force
Parciak, T., Geys, L., Helme, A., van der Mei, I., Hillert, J., Schmidt, H., Salter, A., Zakaria, M., Middleton, R., Stahmann, A., Dobay, P., Hernandez Martinez-Lapiscina, E., Iaffaldano, P., Plueschke, K., Rojas, J. I., Sabidó, M., Magyari, M., van der Walt, A., Arickx, F., Comi, G., & 1 others, Mar 2024, In: Multiple Sclerosis Journal. 30, 3, p. 396-418 23 p.Research output: Contribution to journal › Article › Other › peer-review
Open Access5 Citations (Scopus)
Prizes
-
-
MS Australia President’s Medal
Van Der Walt, Anneke (Recipient), 2022
Prize: Prize (including medals and awards)
-
-
-
-
Leveraging real-world evidence to inform outcomes in MS: Novartis-sponsored seminar
Anneke Van Der Walt (Contributor)
2023 → …Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
Neuroimmunology and MS updates. National Webinar
Anneke Van Der Walt (Contributor)
2022Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
PACTMAN, PACTRIMS. Symptomatic treatment of MS
Anneke Van Der Walt (Contributor)
2022Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
Royal Australasian College of Physicians (RACP) Continuing Medical Education Program. Update on treatment and new frontiers in Multiple Sclerosis
Anneke Van Der Walt (Contributor)
2021Activity: Community Talks, Presentations, Exhibitions and Events › Public event
-
Australia National University MS Symposium: COVID management update.
Anneke Van Der Walt (Contributor)
2021Activity: Community Talks, Presentations, Exhibitions and Events › Public event